The antitubercular activity of SRT and RES was evaluated in an acute and chronic infection model of C57BL/6 mice (12). Female C57BL/6 mice (6 to 8 weeks old) were infected aerosolly with Mtb H37Rv or Erdman. Three to four animals were sacrificed on day 1 to determine the number of bacteria implanted in the lungs. Treatment was initiated 7 or 40 days after infection in the acute and chronic model, respectively. Drugs were administered by gavage once a day, 6 days a week. Mice were sacrificed at predetermined time points followed by harvesting of tissues and enumeration of Mtb CFU. A total of seven experiments (five acute and two chronic) were performed. All mice were housed in a biosafety level 3 (BSL3) laboratory and treated humanely. The Mac-SIRT1 KO mice (30) were a gift from X. Li (U.S. National Institute of Environmental Health Sciences). A total of three experiments were performed with Mac-SIRT1 KO and their littermate controls.
Do you have any questions about this protocol?
Post your question to gather feedback from the community. We will also invite the authors of this article to respond.